CORD-19:013ce450f63ae2496b92f987e35b55125a43947f / 970-1253 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/013ce450f63ae2496b92f987e35b55125a43947f","sourcedb":"CORD-19","sourceid":"013ce450f63ae2496b92f987e35b55125a43947f","text":"Whether the problems encountered with oral administration of soluble protein antigens can be overcome by the use of improved mucosal adjuvants [muranyl dipeptide, immune stimulating complexes (ISCOMs), cholera or Escherichia coli enterotoxins, avridine, proteosomes, cytokines, etc.]","tracks":[{"project":"Epistemic_Statements","denotations":[{"id":"T2","span":{"begin":0,"end":283},"obj":"Epistemic_statement"}],"attributes":[{"subj":"T2","pred":"source","obj":"Epistemic_Statements"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T1","span":{"begin":202,"end":209},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0015766"},{"subj":"T1","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"Epistemic_Statements","color":"#93d7ec","default":true},{"id":"CORD-19-PD-MONDO","color":"#ece793"}]}]}}